A citation-based method for searching scientific literature

Jada G Hamilton, Heather Symecko, Kelsey Spielman, Kelsey Breen, Rebecca Mueller, Amanda Catchings, Magan Trottier, Erin E Salo-Mullen, Ibrahim Shah, Anna Arutyunova, Melissa Batson, Rebecca Gebert, Stacy Pundock, Elizabeth Schofield, Kenneth Offit, Zsofia K Stadler, Karen Cadoo, Maria I Carlo, Vivek Narayan, Kim A Reiss, Mark E Robson, Susan M Domchek. Genet Med 2021
Times Cited: 10







List of co-cited articles
35 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Mainstream consent programs for genetic counseling in cancer patients: A systematic review.
Tahlia Scheinberg, Alison Young, Henry Woo, Annabel Goodwin, Kate L Mahon, Lisa G Horvath. Asia Pac J Clin Oncol 2021
17
40

Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.
Mary B Daly, Tuya Pal, Michael P Berry, Saundra S Buys, Patricia Dickson, Susan M Domchek, Ahmed Elkhanany, Susan Friedman, Michael Goggins, Mollie L Hutton,[...]. J Natl Compr Canc Netw 2021
217
40

Implementing Systematic Genetic Counseling and Multigene Germline Testing for Individuals With Pancreatic Cancer.
Anu Chittenden, Sigurdis Haraldsdottir, Chinedu Ukaegbu, Meghan Underhill-Blazey, Shraddha Gaonkar, Hajime Uno, Lauren K Brais, Kimberly Perez, Brian M Wolpin, Sapna Syngal,[...]. JCO Oncol Pract 2021
8
37

Implementation of an Embedded In-Clinic Genetic Testing Station to Optimize Germline Testing for Patients with Pancreatic Adenocarcinoma.
Evan J Walker, Dena Goldberg, Kelly M Gordon, Christina Pedley, Julia Carnevale, Pelin Cinar, Eric A Collisson, Margaret A Tempero, Andrew H Ko, Amie M Blanco,[...]. Oncologist 2021
4
75

Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer.
Talia Golan, Pascal Hammel, Michele Reni, Eric Van Cutsem, Teresa Macarulla, Michael J Hall, Joon-Oh Park, Daniel Hochhauser, Dirk Arnold, Do-Youn Oh,[...]. N Engl J Med 2019
952
30

A Comparison of Patient-Reported Outcomes Following Consent for Genetic Testing Using an Oncologist- or Genetic Counselor-Mediated Model of Care.
Jeanna M McCuaig, Emily Thain, Janet Malcolmson, Sareh Keshavarzi, Susan Randall Armel, Raymond H Kim. Curr Oncol 2021
4
75

Economic Evaluation of Population-Based BRCA1/BRCA2 Mutation Testing across Multiple Countries and Health Systems.
Ranjit Manchanda, Li Sun, Shreeya Patel, Olivia Evans, Janneke Wilschut, Ana Carolina De Freitas Lopes, Faiza Gaba, Adam Brentnall, Stephen Duffy, Bin Cui,[...]. Cancers (Basel) 2020
25
20

Universal Tumor DNA BRCA1/2 Testing of Ovarian Cancer: Prescreening PARPi Treatment and Genetic Predisposition.
Janet R Vos, Ingrid E Fakkert, Joanne A de Hullu, Anne M van Altena, Aisha S Sie, Hicham Ouchene, Riki W Willems, Iris D Nagtegaal, Marjolijn C J Jongmans, Arjen R Mensenkamp,[...]. J Natl Cancer Inst 2020
30
20

Comparison of Universal Genetic Testing vs Guideline-Directed Targeted Testing for Patients With Hereditary Cancer Syndrome.
N Jewel Samadder, Douglas Riegert-Johnson, Lisa Boardman, Deborah Rhodes, Myra Wick, Scott Okuno, Katie L Kunze, Michael Golafshar, Pedro L S Uson, Luke Mountjoy,[...]. JAMA Oncol 2021
80
20

Feasibility of screening for Lynch syndrome among patients with colorectal cancer.
Heather Hampel, Wendy L Frankel, Edward Martin, Mark Arnold, Karamjit Khanduja, Philip Kuebler, Mark Clendenning, Kaisa Sotamaa, Thomas Prior, Judith A Westman,[...]. J Clin Oncol 2008
585
20

Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynch syndrome.
Kathleen M Schmeler, Henry T Lynch, Lee-may Chen, Mark F Munsell, Pamela T Soliman, Mary Beth Clark, Molly S Daniels, Kristin G White, Stephanie G Boyd-Rogers, Peggy G Conrad,[...]. N Engl J Med 2006
489
20

Deleterious Germline Mutations in Patients With Apparently Sporadic Pancreatic Adenocarcinoma.
Koji Shindo, Jun Yu, Masaya Suenaga, Shahriar Fesharakizadeh, Christy Cho, Anne Macgregor-Das, Abdulrehman Siddiqui, P Dane Witmer, Koji Tamura, Tae Jun Song,[...]. J Clin Oncol 2017
233
20

Low Referral Rate for Genetic Testing in Racially and Ethnically Diverse Patients Despite Universal Colorectal Cancer Screening.
Charles Muller, Sang Mee Lee, William Barge, Shazia M Siddique, Shivali Berera, Gina Wideroff, Rashmi Tondon, Jeremy Chang, Meaghan Peterson, Jessica Stoll,[...]. Clin Gastroenterol Hepatol 2018
53
20

Association Between Inherited Germline Mutations in Cancer Predisposition Genes and Risk of Pancreatic Cancer.
Chunling Hu, Steven N Hart, Eric C Polley, Rohan Gnanaolivu, Hermela Shimelis, Kun Y Lee, Jenna Lilyquist, Jie Na, Raymond Moore, Samuel O Antwi,[...]. JAMA 2018
260
20

Therapeutic Implications of Germline Testing in Patients With Advanced Cancers.
Zsofia K Stadler, Anna Maio, Debyani Chakravarty, Yelena Kemel, Margaret Sheehan, Erin Salo-Mullen, Kaitlyn Tkachuk, Christopher J Fong, Bastien Nguyen, Amanda Erakky,[...]. J Clin Oncol 2021
30
20

Evaluating Susceptibility to Pancreatic Cancer: ASCO Provisional Clinical Opinion.
Elena M Stoffel, Shannon E McKernin, Randall Brand, Marcia Canto, Michael Goggins, Cassadie Moravek, Arun Nagarajan, Gloria M Petersen, Diane M Simeone, Matthew Yurgelun,[...]. J Clin Oncol 2019
86
20

Racial disparities in breast cancer hereditary risk assessment referrals.
Jennifer M Peterson, Abigail Pepin, Rehema Thomas, Tara Biagi, Elizabeth Stark, Andrew D Sparks, Kerry Johnson, Rebecca Kaltman. J Genet Couns 2020
22
20

Prevalence of germline mutations in cancer predisposition genes in patients with pancreatic cancer.
Robert C Grant, Iris Selander, Ashton A Connor, Shamini Selvarajah, Ayelet Borgida, Laurent Briollais, Gloria M Petersen, Jordan Lerner-Ellis, Spring Holter, Steven Gallinger. Gastroenterology 2015
197
20

Prospective study of germline genetic testing in incident cases of pancreatic adenocarcinoma.
Randall Brand, Erkut Borazanci, Virginia Speare, Beth Dudley, Eve Karloski, Mary Linton B Peters, Lindsey Stobie, Nathan Bahary, Herbert Zeh, Amer Zureikat,[...]. Cancer 2018
53
20


Germline cancer susceptibility gene variants, somatic second hits, and survival outcomes in patients with resected pancreatic cancer.
Matthew B Yurgelun, Anu B Chittenden, Vicente Morales-Oyarvide, Douglas A Rubinson, Richard F Dunne, Margaret M Kozak, Zhi Rong Qian, Marisa W Welch, Lauren K Brais, Annacarolina Da Silva,[...]. Genet Med 2019
115
20

PD-1 Blockade in Tumors with Mismatch-Repair Deficiency.
Dung T Le, Jennifer N Uram, Hao Wang, Bjarne R Bartlett, Holly Kemberling, Aleksandra D Eyring, Andrew D Skora, Brandon S Luber, Nilofer S Azad, Dan Laheru,[...]. N Engl J Med 2015
20

ACG clinical guideline: Genetic testing and management of hereditary gastrointestinal cancer syndromes.
Sapna Syngal, Randall E Brand, James M Church, Francis M Giardiello, Heather L Hampel, Randall W Burt. Am J Gastroenterol 2015
800
20

Hereditary Cancer Risk Using a Genetic Chatbot Before Routine Care Visits.
Shivani Nazareth, Laura Hayward, Emilie Simmons, Moran Snir, Kathryn E Hatchell, Susan Rojahn, Robert Nathan Slotnick, Robert L Nussbaum. Obstet Gynecol 2021
5
40

Mainstream genetic testing for breast cancer patients: early experiences from the Parkville Familial Cancer Centre.
Catherine Beard, Katrina Monohan, Linda Cicciarelli, Paul A James. Eur J Hum Genet 2021
9
22

Referral frequency, attrition rate, and outcomes of germline testing in patients with pancreatic adenocarcinoma.
Evan J Walker, Julia Carnevale, Christina Pedley, Amie Blanco, Salina Chan, Eric A Collisson, Margaret A Tempero, Andrew H Ko. Fam Cancer 2019
11
20

Positive experiences of healthcare professionals with a mainstreaming approach of germline genetic testing for women with ovarian cancer.
Kyra Bokkers, Ronald P Zweemer, Marco J Koudijs, Sanne Stehouwer, Mary E Velthuizen, Eveline M A Bleiker, Margreet G E M Ausems. Fam Cancer 2022
5
40

Process and outcome in communication of genetic information within families: a systematic review.
Clara L Gaff, Angus J Clarke, Paul Atkinson, Stephanie Sivell, Glyn Elwyn, Rachel Iredale, Hazel Thornton, Joanna Dundon, Chris Shaw, Adrian Edwards. Eur J Hum Genet 2007
159
20

Child-Parent Familial Hypercholesterolemia Screening in Primary Care.
David S Wald, Jonathan P Bestwick, Joan K Morris, Ken Whyte, Lucy Jenkins, Nicholas J Wald. N Engl J Med 2016
179
20

Cost-effectiveness analysis of the genetic screening program for familial hypercholesterolemia in The Netherlands.
David Wonderling, Marina A W Umans-Eckenhausen, Dalya Marks, Joep C Defesche, John J P Kastelein, Margaret Thorogood. Semin Vasc Med 2004
96
20

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.
Sue Richards, Nazneen Aziz, Sherri Bale, David Bick, Soma Das, Julie Gastier-Foster, Wayne W Grody, Madhuri Hegde, Elaine Lyon, Elaine Spector,[...]. Genet Med 2015
20

Cost effectiveness analysis of different approaches of screening for familial hypercholesterolaemia.
Dalya Marks, David Wonderling, Margaret Thorogood, Helen Lambert, Steve E Humphries, H Andrew W Neil. BMJ 2002
155
20

A Model for Genome-First Care: Returning Secondary Genomic Findings to Participants and Their Healthcare Providers in a Large Research Cohort.
Marci L B Schwartz, Cara Zayac McCormick, Amanda L Lazzeri, D'Andra M Lindbuchler, Miranda L G Hallquist, Kandamurugu Manickam, Adam H Buchanan, Alanna Kulchak Rahm, Monica A Giovanni, Lauren Frisbie,[...]. Am J Hum Genet 2018
85
20

Population-based genetic testing of asymptomatic women for breast and ovarian cancer susceptibility.
Simone M Rowley, Lyon Mascarenhas, Lisa Devereux, Na Li, Kaushalya C Amarasinghe, Magnus Zethoven, Jue Er Amanda Lee, Alexandra Lewis, James A Morgan, Sharne Limb,[...]. Genet Med 2019
32
20

Oncologist-led BRCA counselling improves access to cancer genetic testing in middle-income Asian country, with no significant impact on psychosocial outcomes.
Sook-Yee Yoon, Siu Wan Wong, Joanna Lim, Syuhada Ahmad, Shivaani Mariapun, Heamanthaa Padmanabhan, Nur Tiara Hassan, Shao Yan Lau, Gaik-Siew Ch'ng, Muzhirah Haniffa,[...]. J Med Genet 2022
6
33

Video-assisted genetic counseling in patients with ovarian, fallopian and peritoneal carcinoma.
Catherine H Watson, Michael Ulm, Patrick Blackburn, Linda Smiley, Mark Reed, Rachel Covington, Lauren Bokovitz, Todd Tillmanns. Gynecol Oncol 2016
13
10

A pilot randomized trial of an educational intervention to increase genetic counseling and genetic testing among Latina breast cancer survivors.
Claire C Conley, Eida M Castro-Figueroa, Laura Moreno, Julie Dutil, Jennifer D García, Carolina Burgos, Charité Ricker, Jongphil Kim, Kristi D Graves, Kimlin Tam Ashing,[...]. J Genet Couns 2021
6
16

Veliparib with First-Line Chemotherapy and as Maintenance Therapy in Ovarian Cancer.
Robert L Coleman, Gini F Fleming, Mark F Brady, Elizabeth M Swisher, Karina D Steffensen, Michael Friedlander, Aikou Okamoto, Kathleen N Moore, Noa Efrat Ben-Baruch, Theresa L Werner,[...]. N Engl J Med 2019
398
10

European experts consensus: BRCA/homologous recombination deficiency testing in first-line ovarian cancer.
I Vergote, A González-Martín, I Ray-Coquard, P Harter, N Colombo, P Pujol, D Lorusso, M R Mirza, B Brasiuniene, R Madry,[...]. Ann Oncol 2022
12
10

Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial.
Robert L Coleman, Amit M Oza, Domenica Lorusso, Carol Aghajanian, Ana Oaknin, Andrew Dean, Nicoletta Colombo, Johanne I Weberpals, Andrew Clamp, Giovanni Scambia,[...]. Lancet 2017
883
10

Overall survival in patients with platinum-sensitive recurrent serous ovarian cancer receiving olaparib maintenance monotherapy: an updated analysis from a randomised, placebo-controlled, double-blind, phase 2 trial.
Jonathan A Ledermann, Philipp Harter, Charlie Gourley, Michael Friedlander, Ignace Vergote, Gordon Rustin, Clare Scott, Werner Meier, Ronnie Shapira-Frommer, Tamar Safra,[...]. Lancet Oncol 2016
284
10

Process evaluation of a culturally targeted video for Latinas at risk of hereditary breast and ovarian cancer.
Alejandra Hurtado-de-Mendoza, Sara Gómez-Trillos, Kristi D Graves, Pilar Carrera, Claudia Campos, Lyndsay Anderson, Andrés Gronda, Halyn Orellana, Beth N Peshkin, Marc D Schwartz,[...]. J Genet Couns 2021
1
100

Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer.
Mansoor R Mirza, Bradley J Monk, Jørn Herrstedt, Amit M Oza, Sven Mahner, Andrés Redondo, Michel Fabbro, Jonathan A Ledermann, Domenica Lorusso, Ignace Vergote,[...]. N Engl J Med 2016
10

Survey on Physicians' Knowledge and Training Needs in Genetic Counseling in Germany.
Julia Dick, Viktoria Aue, Simone Wesselmann, Anne Brédart, Sylvie Dolbeault, Peter Devilee, Dominique Stoppa-Lyonnet, Rita K Schmutzler, Kerstin Rhiem. Breast Care (Basel) 2021
1
100

Olaparib plus Bevacizumab as First-Line Maintenance in Ovarian Cancer.
Isabelle Ray-Coquard, Patricia Pautier, Sandro Pignata, David Pérol, Antonio González-Martín, Regina Berger, Keiichi Fujiwara, Ignace Vergote, Nicoletta Colombo, Johanna Mäenpää,[...]. N Engl J Med 2019
624
10

Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial.
Eric Pujade-Lauraine, Jonathan A Ledermann, Frédéric Selle, Val Gebski, Richard T Penson, Amit M Oza, Jacob Korach, Tomasz Huzarski, Andrés Poveda, Sandro Pignata,[...]. Lancet Oncol 2017
957
10

Preventing future cancers by testing women with ovarian cancer for BRCA mutations.
Janice S Kwon, Molly S Daniels, Charlotte C Sun, Karen H Lu. J Clin Oncol 2010
53
10

Evaluation of telephone genetic counselling to facilitate germline BRCA1/2 testing in women with high-grade serous ovarian cancer.
Erin Tutty, Lara Petelin, Joanne McKinley, Mary-Anne Young, Bettina Meiser, Victoria M Rasmussen, Rowan Forbes Shepherd, Paul A James, Laura E Forrest. Eur J Hum Genet 2019
12
10

Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer.
Antonio González-Martín, Bhavana Pothuri, Ignace Vergote, René DePont Christensen, Whitney Graybill, Mansoor R Mirza, Colleen McCormick, Domenica Lorusso, Paul Hoskins, Gilles Freyer,[...]. N Engl J Med 2019
731
10

Modified panel-based genetic counseling for ovarian cancer susceptibility: A randomized non-inferiority study.
Jeanna M McCuaig, Alicia A Tone, Manjula Maganti, Tina Romagnuolo, Nicole Ricker, Jennifer Shuldiner, Gary Rodin, Tracy Stockley, Raymond H Kim, Marcus Q Bernardini. Gynecol Oncol 2019
9
11


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.